NasdaqCM - Delayed Quote USD

Palvella Therapeutics, Inc. (PVLA)

Compare
13.50
+0.19
+(1.43%)
At close: January 30 at 4:00:00 PM EST
13.01
-0.54
(-3.99%)
Pre-market: 5:13:40 AM EST

Research analysis

Analyst recommendations

  • Strong buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analysts' price targets

30.00
34.00 Average
13.50 Current
38.00 High

Earnings estimate

Currency in USD Current qtr. (Dec 2024)Next qtr. (Mar 2025)Current year (2024)Next year (2025)
No. of analysts 2222
Avg. Estimate -0.55-0.67-3.69-2.77
Low estimate -0.7-0.86-4.37-3.93
High estimate -0.39-0.48-3.02-1.6
Year ago EPS -------3.69

Revenue estimate

Currency in USD Current qtr. (Dec 2024)Next qtr. (Mar 2025)Current year (2024)Next year (2025)
No. of analysts 2222
Avg. Estimate ----26.5k--
Low estimate --------
High estimate ----53k--
Year ago sales ------26.5k
Sales growth (year/est) -------100.00%

EPS trend

Currency in USD Current qtr. (Dec 2024)Next qtr. (Mar 2025)Current year (2024)Next year (2025)
Current estimate -0.55-0.67-3.69-2.77
7 days ago -0.55-0.67-3.69-2.77
30 days ago 0000
60 days ago 0000
90 days ago 0000

EPS revisions

Currency in USD Current qtr. (Dec 2024)Next qtr. (Mar 2025)Current year (2024)Next year (2025)
Up last 7 days --------
Up last 30 days --------
Down last 7 days --------
Down last 30 days --------

Growth estimates

Current qtr.Next qtr.Current yearNext year
PVLA ------25.17%
S&P 500 9.01%10.57%14.00%13.70%

Upgrades & downgrades

Reiterates HC Wainwright & Co.: Buy to Buy 1/10/2025
Reiterates HC Wainwright & Co.: Buy to Buy 1/3/2025
Initiated HC Wainwright & Co.: Buy 12/26/2024

Related tickers